TD-1607 SAD Study in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
TD-1607, administered intravenously as single doses, will be investigated in healthy subjects to assess its tolerability, safety, and pharmacokinetics.
Epistemonikos ID: 28d747abdd1b6b4e96ee1b64c952713176121c3d
First added on: May 11, 2024